Grants for Researchers

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Bone Marrow Failure award supports building a multiomic atlas from well-annotated human bone marrow failure samples, intended as an open-access resource for the research and clinical communities. Eligibility is described as unrestricted, open to any type of entity subject to additional clarifications, so a range of research organizations may apply. Applications must include a robust data resource sharing plan. No award amounts are listed, and detailed eligibility is deferred to the full announcement.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Bone Marrow Failure Investigator-Initiated Research Award supports translational and clinical research, preclinical model studies, and IND-enabling work, but does not support clinical trials. Eligibility is described as unrestricted, open to any type of entity subject to additional clarifications, so a range of research organizations may apply; a Partnering PI option is available. Preliminary data relevant to the proposed project are required. No award amounts are listed.

National Institutes of Health · Amount varies

This NIH R01 grant supports development of novel theory and methods to understand how genetic and non-genetic factors shape complex human traits, using interdisciplinary modeling and large-scale datasets. It is a research grant aimed primarily at universities, research institutions, and similar eligible organizations, including various minority-serving institutions, tribal entities, and foreign organizations. No award amounts are specified. Clinical trials are not allowed under this opportunity, and the eligibility list is research-institution oriented rather than open to nonprofits, small businesses, or individuals broadly.

National Institutes of Health · Up to $350K

This NIH/NCI R01 grant funds secondary analysis and integration of existing datasets to study cancer risk and related outcomes such as survival and treatment response. It is a research grant for universities, research institutions, and similar eligible organizations, including various minority-serving institutions, tribal entities, and foreign organizations. The award maximum is about $350,000. Eligibility is oriented toward research institutions rather than nonprofits, small businesses, or individuals broadly, and applicants typically need access to relevant existing data.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Parkinson's Research Program Investigator-Initiated Research Award supports rigorous, multidisciplinary, high-impact Parkinson's disease research, and clinical trials are allowed. Eligibility is described as unrestricted, open to any type of entity subject to additional clarifications, so a range of research organizations may apply; a Partnering PI option allows up to two partnering PIs. Research must address at least one program focus area, and preliminary data are required. No award amounts are listed.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Parkinson's Research Program Early Investigator Research Award supports early-career investigators, with one funding level for fellows (requiring a mentor) and another for early-career independent investigators. Eligibility is described as unrestricted, open to any type of entity subject to additional clarifications, so a range of research organizations may apply; clinical trials are not allowed. Research must address at least one program focus area. No award amounts are listed.

National Institutes of Health · Amount varies

This NIH U01 grant funds research using expanded-access data for investigational drugs to help intermediate-size populations of ALS patients who are not eligible for ongoing clinical trials; a clinical trial is required. Eligibility is narrow: applicants must be clinical trial sites participating in a phase 2/3 or phase 3 trial sponsored by a small business that is the FDA-designated sponsor of the relevant drug. Foreign organizations and foreign components are not eligible. No award amounts are listed. This is a highly specialized opportunity tied to an existing small-business-sponsored ALS drug trial, not a general grant.

National Institutes of Health · Up to $300K

This NIH/NCI R33 grant funds advanced development and technical validation of emerging technologies for molecular or cellular characterization of cancer and biospecimen handling, where feasibility has been shown but further validation is needed; clinical trials are not allowed. It is a research grant for universities, research institutions, and similar eligible organizations, and foreign organizations and foreign components are eligible. The award maximum is about $300,000. Eligibility is oriented toward research institutions rather than nonprofits, businesses, or individuals broadly.

National Institutes of Health · Up to $150K

This NIH/NCI R61 grant funds early-stage, proof-of-concept development of innovative technologies for molecular or cellular characterization of cancer and biospecimen handling; clinical trials are not allowed. It is a research grant for universities, research institutions, and similar eligible organizations, and foreign organizations and foreign components are eligible. The award maximum is about $150,000. Eligibility is oriented toward research institutions rather than nonprofits, businesses, or individuals broadly.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) award supports translational spinal cord injury research aimed at moving promising ideas toward clinical applications. Eligibility is described as unrestricted, open to any type of entity subject to additional clarifications, so a range of research organizations may apply; an optional Early-Career Partnership allows two principal investigators, at least one early-career. Applications must name at least one spinal cord injury community partner. No award amounts are listed, and the precise eligibility details are deferred to the full announcement.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Vision Research Program award supports translational research that turns a promising discovery into new drugs, devices, or clinical practice guidelines, including preclinical studies, clinical research, or a pilot trial, but not a full-scale clinical trial. Eligibility is described as unrestricted, open to any type of entity subject to additional clarifications, so a range of research organizations may apply; a Partnering PI option allows two investigators. Research must align with the program's focus areas. No award amounts are listed.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Vision Research Program award supports basic through early translational research on eye injury or visual dysfunction related to military exposure, including preclinical and clinical research but not clinical trials. Eligibility is described as unrestricted, open to any type of entity subject to additional clarifications, so a range of research organizations may apply; two funding levels and a Partnering PI option are offered. Research must align with the program's focus areas. No award amounts are listed.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Spinal Cord Injury award supports rapid implementation of clinical trials that could significantly affect the treatment or management of spinal cord injury. Eligibility is described as unrestricted, open to any type of entity subject to additional clarifications, so a range of research organizations may apply; an optional Early-Career Partnership allows two principal investigators. Applications must name at least two spinal cord injury community partners. No award amounts are listed.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Vision Research Program award supports rapid implementation of clinical trials addressing service-connected eye injury and visual dysfunction. Eligibility is described as unrestricted, open to any type of entity subject to additional clarifications, so a range of research organizations may apply. Interventions requiring IND/IDE regulatory authorization must meet specific submission and approval milestones to be considered. Research must align with the program's focus areas. No award amounts are listed.

Defense Health Agency Contracting Activity - DHACA · Amount varies

Department of War (Defense Health Agency) Spinal Cord Injury Research Program Investigator-Initiated Research Award funding studies that could meaningfully advance spinal cord injury research, patient care, or quality of life, from basic through translational science. Eligibility is listed as unrestricted/open to any entity type subject to clarification in the full notice; an early-career partnership option allows two principal investigators. No award amount is specified. The stated eligibility is broad.

Defense Health Agency Contracting Activity - DHACA · Amount varies

Department of War (Defense Health Agency) Spinal Cord Injury Research Program Clinical Translation Research Award funding early-stage clinical research (feasibility, pilot, optimization) to prepare for larger spinal cord injury trials or implementation. Eligibility is listed as unrestricted/open to any entity type subject to clarification in the full notice; applications must name at least two SCI community partners. No award amount is specified. The stated eligibility is broad, but applicants need clinical research capacity and required partnerships.

National Institutes of Health · Amount varies

NIH (NCCIH) R01 funding for mid-phase clinical trials of natural products such as botanicals, dietary supplements, and probiotics that already have strong preliminary data. Intended for research institutions able to conduct hypothesis-driven, milestone-based clinical trials; foreign organizations are not eligible. No dollar amount is stated. It will not support efficacy/effectiveness trials or cancer-treatment trials, and requires substantial prior preliminary data, so it is narrow in scope.

National Institutes of Health · Up to $350K

NIH (NCCIH) phased R61/R33 funding for early-phase clinical trials of natural products (botanicals, probiotics, marketed dietary supplements) with a strong scientific rationale. Suited to research institutions running milestone-driven pharmacokinetic and target-engagement studies; foreign organizations are not eligible. The listed maximum is about $350,000. It is narrow research-only work requiring strong preliminary justification, not a fit for individuals or general nonprofits.

National Institutes of Health · Up to $750K

NIH (NIDA) K12 institutional career-development funding to support mentored research training for clinician-scientists in substance use and substance use disorder research. Intended for institutions that will run a scholar training program; foreign organizations are not eligible and foreign components are not allowed. The listed maximum is about $750,000. This is an institutional training award, not a grant for individuals or general nonprofits.

National Institutes of Health · Up to $1.1M

NIH (NCCIH) R33 funding for early-phase clinical trials of natural products (botanicals, dietary supplements, probiotics) to confirm target engagement and inform whether further clinical research is warranted. Intended for research institutions; foreign organizations are not eligible. The listed maximum is about $1,050,000. It will not support efficacy or effectiveness trials and requires strong preliminary data, making it narrow research-only funding.